Lung Foundation Australia strongly supports today’s announcement of a $1.89 billion investment into a transformation of health and medical research in Australia by the Federal Government.
Lung Foundation Australia CEO Mark Brooke said the Health Research for a Future Made in Australia package was a watershed moment for Australians living with lung cancer and lung diseases.
“Lung Foundation Australia has advocated tirelessly when it comes to equitable outcomes for cancer diagnoses and treatments in our country, and we know the more investment in vital research, the greater the benefits and savings on the health care system in the long run,” Mr Brooke said.
“We commend Minister Butler and it’s wonderful to see the focus on the new 10-Year Low Survival Cancers Mission, the 10-Year Reducing Health Inequities Mission and continuing existing streams of lifechanging MRFF funding in particular.
“We know that if Australians with lung cancer are diagnosed at Stage I, their five-year survival rate nears 70 per cent.”
Mr Brooke said the funding package came at a pivotal time for lung cancer investment and research in Australia, with the recently released Australian Cancer Plan and the imminent start of a National Lung Cancer Screening program both monumental steps towards more equitable outcomes for cancer diagnoses and treatments across the country.
“These outcomes are a culmination of years of listening, consultation and taking on feedback from thousands of knowledgeable Australians; from the general public to the health sector, and government agencies,” he said.
“We look forward to continuing to work alongside the Albanese Government as they develop a National Health and Medical Research Strategy, another important part of today’s announcement, and extend our congratulations to the lung disease and lung cancer researchers whose vital work will be able to continue and be expanded through this commitment.”
Want to partner with us?
Lung Foundation Australia is proud to partner with the Australian lung research community. For strategically aligned research projects, we can provide advisory support, consumer engagement services, access to our community networks and input for translation to patient and policy contexts. We encourage research teams to connect with us early during concept development to discuss potential partnership opportunities.
For media enquiries please contact:
Anna Hilton
Media and Communications Specialist
0408 191 192
Was this page helpful?
Good job! Please give your positive feedback
How could we improve this post? Please Help us.
